Treatment decision regret in long-term survivors after radical prostatectomy: a longitudinal study
- PMID: 36545828
- DOI: 10.1111/bju.15955
Treatment decision regret in long-term survivors after radical prostatectomy: a longitudinal study
Abstract
Objectives: To investigate prevalence, course, and predictors of longitudinal decision regret in long-term prostate cancer (PCa) survivors treated by radical prostatectomy (RP).
Patients and methods: A total of 1003 PCa survivors from the multicentre German Familial PCa Database completed questionnaires on average 7 years after RP in 2007 and at follow-up 13 years later in 2020. Patients completed standardised patient-reported outcome measures on decision regret, decision-making, health-related quality of life, and psychosocial factors. Hierarchical multivariable logistic regression was used to assess predictors of longitudinal decision regret.
Results: Decision regret increased significantly over time (9.0% after 6.9 years in 2007 and 12% after 19 years in 2020; P = 0.009). Favourable localised PCa (odds ratio [OR] 1.97, 95% confidence interval [CI] 1.05-3.68), decision regret in 2007 (OR 6.38, 95% CI 3.55-11.47), and a higher depression score (OR 1.37, 95% CI 1.03-1.83) were associated with decision regret in 2020. Shared decision-making (OR 0.55, 95% CI 0.33-0.93) was associated with less decision regret.
Conclusion: The findings of the present study underline the perseverance of decision regret in long-term PCa survivors and the definitive need for involving patients in the decision-making process to mitigate regret over the long term.
Keywords: #PCSM; #ProstateCancer; #uroonc; decision-making; patient-reported outcome measures; prostatectomy; prostatic neoplasms; quality of life; regret.
© 2022 The Authors. BJU International published by John Wiley & Sons Ltd on behalf of BJU International.
References
-
- Mottet N, van den Bergh RCN, Briers E et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate Cancer-2020 update. Part 1: Screening, diagnosis, and local treatment with curative intent. Eur Urol 2021; 79: 243-62
-
- Hamdy FC, Donovan JL, Lane JA et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 2016; 375: 1415-24
-
- Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008; 148: 435-48
-
- Morris BB, Farnan L, Song L et al. Treatment decisional regret among men with prostate cancer: Racial differences and influential factors in the North Carolina health access and prostate cancer treatment project (HCaP-NC). Cancer 2015; 121: 2029-35
-
- Hoffman RM, Lo M, Clark JA et al. Treatment decision regret among long-term survivors of localized prostate cancer: Results from the prostate cancer outcomes study. J Clin Oncol 2017; 35: 2306-14
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
